BLS ASX · Consumer Staples

BLS Pharmaceuticals Ltd

Announcements, last 12 months
28
Price sensitive, last 12 months
10
Followed on InvestorPA
Moderate (top 13% of companies)

Latest announcements

Released Headline Actions
Letter to Shareholders re Annual General Meeting
Notice of Annual General Meeting/Proxy Form
Q1 FY2027 Quarterly Activities Update Price sensitive AI summary
BLS Quarterly Activities Report September 2026 Revised Price sensitive AI summary
Quarterly Activities/Appendix 4C Cash Flow Report Price sensitive AI summary
Ceasing to be a substantial holder
Becoming a substantial holder
AGM Date and Director Nominations
Application for quotation of securities - BLS
Application for quotation of securities - BLS

Sign in to see all BLS announcements.

Guidance history

21 Oct 2026 FY27 revenue guidance reaffirmed at $105m to $115m, adjusted EBITDA margin 23% to 26%
15 Oct 2026 FY27 revenue guidance of $105 million to $115 million and adjusted EBITDA margin of 23% to 26%
15 Oct 2026 FY27 revenue guidance: $105 million to $115 million, adjusted EBITDA margin: 23% to 26%

Sign in to see the full guidance history.

Most followed in Consumer Staples

  • WOW Woolworths Group Ltd
  • COL Coles Group Ltd
  • BIO Biome Australia Ltd
  • EDV Endeavour Group Ltd
  • A2M The a2 Milk Company Ltd
  • TWE Treasury Wine Estates Ltd
  • AVG Australian Vintage Ltd
  • CCO The Calmer Co International Ltd
Follow BLS to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in